Last updated on November 2017

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder


Brief description of study

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder

Detailed Study Description

A clinical research study to evaluate the safety, effectiveness and tolerability of an investigational drug for individuals with Major Depressive Disorder.

Clinical Study Identifier: TX8331

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Karen Godoy

Pacific Clinical Research Medical Group
Upland, CA USA
  Connect »